Magnesium therapy in new-onset atrial fibrillation
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (16) , 1227-1229
- https://doi.org/10.1016/0002-9149(94)90190-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter studyJournal of the American College of Cardiology, 1991
- Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass graftingThe Annals of Thoracic Surgery, 1991
- Effect of intravenous magnesium sulfate on supraventricular tachycardiaThe American Journal of Cardiology, 1989
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Esmolol: Safety and Efficacy in Postoperative Cardiothoracic Patients with Supraventricular TachyarrhythmiasChest, 1988
- Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus RhythmAnnals of Internal Medicine, 1987
- Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxinThe American Journal of Cardiology, 1986
- Magnesium and potassium therapy in multifocal atrial tachycardiaAmerican Heart Journal, 1985